Kara L Kopper is a prominent inventor based in Rancho Santa Margarita, CA (US). She has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma and optic neuropathy. With a total of 2 patents, her work focuses on innovative methods to improve eye health and prevent vision loss.

Latest Patents

Kopper's latest patents include groundbreaking research on targeting the reverse mode of the Na⁺/Ca²⁺ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy. This method involves administering a pharmaceutical composition to retinal ganglion cells and their axons, which contains active ingredients that block the reverse mode of the sodium/calcium exchanger. Additionally, she has developed a method for reducing intraocular pressure in the mammalian eye, which includes pharmaceutical compositions that treat glaucoma and ocular hypertension. The active ingredients in this treatment comprise potassium channel blockers, such as quinine and tremogenic indole alkaloids.

Career Highlights

Kopper is currently associated with Allergan, Inc., a leading company in the pharmaceutical industry. Her work at Allergan has allowed her to focus on developing innovative treatments that address critical eye health issues.

Collaborations

Throughout her career, Kopper has collaborated with notable colleagues, including Joseph S Adorante and Elizabeth WoldeMussie. These partnerships have contributed to her success in advancing ophthalmic research and developing effective treatments.

Conclusion

Kara L Kopper is a distinguished inventor whose work has significantly impacted the field of ophthalmology. Her innovative patents and collaborations highlight her commitment to improving eye health and advancing medical science.